- Home
- PHGE vs SUGP Comparison
PHGE vs SUGP Comparison
Compare PHGE & SUGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- SUGP
- Stock Information
- Founded
- PHGE 2015
- SUGP 1998
- Country
- PHGE Israel
- SUGP Hong Kong
- Employees
- PHGE N/A
- SUGP N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- SUGP
- Sector
- PHGE Health Care
- SUGP
- Exchange
- PHGE Nasdaq
- SUGP NYSE
- Market Cap
- PHGE 11.0M
- SUGP 9.6M
- IPO Year
- PHGE N/A
- SUGP 2024
- Fundamental
- Price
- PHGE $0.44
- SUGP $0.46
- Analyst Decision
- PHGE Strong Buy
- SUGP
- Analyst Count
- PHGE 1
- SUGP 0
- Target Price
- PHGE $15.00
- SUGP N/A
- AVG Volume (30 Days)
- PHGE 284.6K
- SUGP 151.5K
- Earning Date
- PHGE 08-13-2025
- SUGP 07-21-2025
- Dividend Yield
- PHGE N/A
- SUGP N/A
- EPS Growth
- PHGE N/A
- SUGP N/A
- EPS
- PHGE N/A
- SUGP N/A
- Revenue
- PHGE N/A
- SUGP $25,478,980.00
- Revenue This Year
- PHGE N/A
- SUGP N/A
- Revenue Next Year
- PHGE N/A
- SUGP N/A
- P/E Ratio
- PHGE N/A
- SUGP N/A
- Revenue Growth
- PHGE N/A
- SUGP 25.07
- 52 Week Low
- PHGE $0.34
- SUGP $0.35
- 52 Week High
- PHGE $3.86
- SUGP $3.25
- Technical
- Relative Strength Index (RSI)
- PHGE 43.34
- SUGP 33.24
- Support Level
- PHGE $0.43
- SUGP $0.43
- Resistance Level
- PHGE $0.48
- SUGP $0.52
- Average True Range (ATR)
- PHGE 0.05
- SUGP 0.07
- MACD
- PHGE 0.00
- SUGP -0.01
- Stochastic Oscillator
- PHGE 58.82
- SUGP 32.12
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About SUGP SU GROUP HLDGS LTD
SU Group Holdings Ltd and its subsidiaries is an integrated security-related services company. The company has two reportable segments: security-related engineering services, and security guarding and screening services and related vocational training services. The company generates the majority of its revenue from the security-related engineering services segment. Geographically operates in Hong Kong, and Other foreign countries, with maximum revenue from Kong Kong.